Charles Fouillade - Publications

Université Paris 5 
Notch3 signaling, Small vessel disease of the brain, Smooth muscle cell, Transcriptome, Myogenic response

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Cognat E, Baron-Menguy C, Domenga-Denier V, Cleophax S, Fouillade C, Monet-Leprêtre M, Dewerchin M, Joutel A. Archetypal Arg169Cys mutation in NOTCH3 does not drive the pathogenesis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy via a loss-of-function mechanism. Stroke. 45: 842-9. PMID 24425116 DOI: 10.1161/STROKEAHA.113.003339  0.8
2013 Fouillade C, Baron-Menguy C, Domenga-Denier V, Thibault C, Takamiya K, Huganir R, Joutel A. Transcriptome analysis for Notch3 target genes identifies Grip2 as a novel regulator of myogenic response in the cerebrovasculature. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 76-86. PMID 23117660 DOI: 10.1161/ATVBAHA.112.251736  0.36
2012 Fouillade C, Monet-Leprêtre M, Baron-Menguy C, Joutel A. Notch signalling in smooth muscle cells during development and disease. Cardiovascular Research. 95: 138-46. PMID 22266753 DOI: 10.1093/cvr/cvs019  0.8
2008 Fouillade C, Chabriat H, Riant F, Mine M, Arnoud M, Magy L, Bousser MG, Tournier-Lasserve E, Joutel A. Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain. Human Mutation. 29: 452. PMID 18273901 DOI: 10.1002/humu.9527  0.8
Show low-probability matches.